Drug Profile
Diabetes type 1 vaccine - Sanofi/Vactech
Latest Information Update: 04 Apr 2022
Price :
$50
*
At a glance
- Originator sanofi pasteur; Vactech
- Developer Sanofi Pasteur; Vactech
- Class Antihyperglycaemics; Diabetes mellitus vaccines; Vaccines
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Type 1 diabetes mellitus
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for research development in Type-1 diabetes mellitus(Prevention) in Finland (Parenteral)